-
Signature
-
/s/ Andrea Ellis
-
Issuer symbol
-
BBIO
-
Transactions as of
-
01 Apr 2025
-
Net transactions value
-
-$768,000
-
Form type
-
4
-
Filing time
-
03 Apr 2025, 17:11:15 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BBIO |
Common Stock |
Options Exercise |
$253,500 |
+30,000 |
+250% |
$8.45 |
42,000 |
01 Apr 2025 |
Direct |
F1 |
| transaction |
BBIO |
Common Stock |
Sale |
$1,021,500 |
-30,000 |
-71% |
$34.05 |
12,000 |
01 Apr 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
BBIO |
Stock Option (right to buy) |
Options Exercise |
$0 |
-30,000 |
-29% |
$0.000000 |
74,921 |
01 Apr 2025 |
Common Stock |
30,000 |
$8.45 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: